POSTER SESSION VI Wednesday, March 26, 2003   —  1:00 - 4:00 PM Exhibit Hall A - C GENITOURINARY PATHOLOGY 84 Prostate Specific Membrane Antigen (PSMA): Target Validation and Prognostic Significance in Prostate Cancer (PCA) (762) JS Ross, K Gray, R Mosher, J Deeds, HAG Fisher, P Kaur, CE Sheehan, BVS Kallakury Albany Medical College, Albany, NY; Millennium Pharmaceuticals, Inc., Cambridge, MA 85 The Value of Microvessel Count and Color Doppler Flow in Assessing Prostate Needle Biopsy (638) HB Barsoum, NM Wilson, HN Tawfik, MM Refaat, MA Abolnoor, A Abdelwahed, TA Kamal, FA Tantawy, AM Masood Ahmed Maher Teaching Hospital, Cairo, Egypt; Mational Cancer Insatitute, Cairo, Egypt; Banha MedicaL School, Banha, Egypt 86 Follow Up of High Grade Prostatic Intraepithelial Neoplasia and Atypical Small Acinar Proliferation in a Highly Screened Patient Population (769) C Schlesinger, DG Bostwick Bostwick Laboratories, Richmond, VA 87 Interobserver Reproducibility of Gleason Grading of Prostate Carcinoma in Japan (750) T Oyama, W Allsbrook, K Kurokawa, Y Mikami, A Segawa, T Sano, T Nakajima, K Suzuki, K Mangold, J Epstein Gunma University, Maebashi, Gunma, Japan; Medical College of Georgia, Augusta, GA; Tohoku University, Sendai, Miyagi, Japan; Gunma University of Health Sciences, Maebashi, Gunma, Japan 88 Heterogeneity of Gleason Grade in Multifocal Adenocarcinoma of the Prostate (634) R Arora, TM Ulbright, MO Koch, JN Eble, L Cheng Indiana University School of Medicine, Indianapolis, IN 89 p27 Mediated Cell Cycle Regulation Appears Independent of Skp2 Expression in Prostate and Renal Cancers (708) BVS Kallakury, CE Sheehan, S Karikehalli, P Kaur, N Rassaei, N Azumi, JS Ross Albany Medical College, Albany, NY; Georgetown University Hospital, Washington, DC 90 Expression of $-Catenin in Prostate Adenocarcinomas: A Comparison with Colorectal Adenocarcinomas (644) TA Bismar, PA Humphrey, HL Wang Washington University, St. Louis, MO 91 Expression of NFkB Pathway Proteins in Prostate Cancer (PCA) and Correlation with Clinical Outcomes (712) P Kaur, BVS Kallakury, CE Sheehan, JS Ross Albany Medical College, Albany, NY; Georgetown University Hospital, Washington, DC 92 Prostate Carcinoma with Squamous Differentiation: An Analysis of 33 Cases (754) AV Parwani, JD Kronz, EM Genega, P Gaudin, S Chang, JI Epstein The Johns Hopkins Hospital, Baltimore, MD; Memorial Sloan Kettering Cancer Center, New York, NY 93 Quantitation of Prostate Conventional Histologic Parameters Are Useful To Distinguish Paramalignant from Malignant Disease (780) LC Silva, P Saldiva, F Ellinger, B Luna Filho, V Capelozzi, L Antonangelo University of Marilia, Marilia, SP, Brazil; University of Sao Paulo, Sao Paulo, SP, Brazil; Federal University of Sao Paulo, Sao Paulo, SP, Brazil 94 Prediction of Large Prostate Cancer Volume by Multiple Core Biopsies (692) L Haggarth, C Busch, L Egevad St Goran Hospital, Stockholm, Sweden; Uppsala University Hospital, Uppsala, Sweden; Karolinska Hospital, Stockholm, Sweden 95 Allelic Losses on 8p22 Are Associated with Perineural Invasion in Localized Prostate Cancer (682) G Fromont, V Joulin, K Chantrel-Groussard, J Blin, G Vallancien, P Validire, A Latil, O Cussenot Institut Mutualiste Montsouris, Paris, France; UroGene, Paris, France 96 Differential Gene Expression in Hormone-Refractory Prostate Cancer (681) G Fromont, L Chene, M Vidaud, I Mahouche, G Vallancien, P Validire, A Latil, O Cussenot Institut Mutualiste Montsouris, Paris, France; UroGene, Paris, France 97 Intraoperative Frozen Section Analysis during Nerve Sparing Radical Laparoscopic Prostatectomy (680) G Fromont, H Baumert, B Guilloneau, P Validire, G Vallancien Institut Mutualiste Montsouris, Paris, France 98 Differential Regulation of the PKC Super Family Determines the Phenotypic Behaviour of Androgen-Independent Prostate Epithelial Cells (711) V Karavana, PH Smith, C Beesley, A Bee, J Adamson, CS Foster University of Liverpool, United Kingdom 99 Diagnostic Prostate Biopsies Evaluated by Frozen Sections. A Two Year Experience (683) J Furman, IM Thompson, D Troyer The University of Texas.Health Science Center, San Antonio, TX 100 Characterization of Prostate Cancers Potentially Amenable to Tyrosine Kinase Inhibitors of Platelet Derived Growth Factor Receptor (675) A Fecko, RL Shen, AM Chinnaiyan, MA Rubin University of Michigan School of Medicine, Ann Arbor, MI 101 Predictive Value of the Interaction of E-Cadherin and EZH2 Protein Expression in Prostate Cancer (717) R Kuefer, RL Shen, L Schumacher, DR Rhodes, T Mattfeldt, AM Chinnaiyan, MA Rubin University of Ulm, Ulm, Germany; University of Michigan School of Medicine, Ann Arbor, MI; Brigham and Women's Hospital, Boston, MA 102 Development of Prostate Cancer Biomarkers To Indentify Men Suitable for Watchful Waiting Protocols (758) DR Rhodes, AM Chinnaiyan, MA Rubin University of Michigan School of Medicine, Ann Arbor, MI 103 Combined Laser Capture Microdissection and Micro-Serial Analysis of Gene Expression for Generation of Cell-Specific Expression Profiles of Human Prostate Cancer Tissue (660) JH Cho, C Rago, X Wang, K-A Do, TJ McDonnell MDAnderson Cancer Center, Houston, TX; Johns Hopkins School/ Medicine, Baltimore, MD